Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chim C Lang

Showing results (1-10 of 270) with videos related to

Pageof 27
Sort By:
Cardiovascular Therapeutics|December 15, 2015
ObituaryChim C Lang
Circulation|January 31, 2018
Repurposing Metformin for Cardiovascular DiseaseGraham Rena, Chim C Lang
Heart (British Cardiac Society)|February 21, 2006
Non-cardiac comorbidities in chronic heart failureChim C Lang, Donna M Mancini
Nature Reviews. Cardiology|January 16, 2013
Targeting the renin-angiotensin-aldosterone system in heart failureChim C Lang, Allan D Struthers
Heart Failure Clinics|October 10, 2022
Glucose-Lowering and Metabolic Effects of SGLT2 InhibitorsIfy R Mordi, Chim C Lang
Circulation|September 6, 2006
Letter by Struthers et al regarding article, "cross-sectional relations of multiple biomarkers from distinct biological pathways to brachial artery endothelial function"Allan D Struthers, Chim C Lang
Cardiovascular Therapeutics|May 12, 2009
Thiazolidinediones and the influence of media adverse reporting on prescribing attitudes in practice (TZD-IMPACT) studyJacob George, Stuart Hannah, Chim C Lang
Vascular Health and Risk Management|June 18, 2015
Angiotensin receptor-neprilysin inhibitors: clinical potential in heart failure and beyondJagdeep S S Singh, Chim C Lang
Journal of Cardiac Failure|October 10, 2007
Prognostic significance and measurement of exercise-derived hemodynamic variables in patients with heart failureChim C Lang, Piergiuseppe Agostoni, Donna M Mancini
Circulation|January 28, 2020
Letter by Mordi et al Regarding Article, "Metformin Use and Clinical Outcomes Among Patients With Diabetes Mellitus With or Without Heart Failure or Kidney Dysfunction: Observations From the SAVOR-TIMI 53 Trial"Ify R Mordi, Mohapradeep Mohan, Chim C Lang
Pageof 27

Showing results (1-10 of 270) with videos related to

Sort By:
Pageof 27
Cardiovascular Therapeutics|December 15, 2015
ObituaryChim C Lang
Circulation|January 31, 2018
Repurposing Metformin for Cardiovascular DiseaseGraham Rena, Chim C Lang
Heart (British Cardiac Society)|February 21, 2006
Non-cardiac comorbidities in chronic heart failureChim C Lang, Donna M Mancini
Nature Reviews. Cardiology|January 16, 2013
Targeting the renin-angiotensin-aldosterone system in heart failureChim C Lang, Allan D Struthers
Heart Failure Clinics|October 10, 2022
Glucose-Lowering and Metabolic Effects of SGLT2 InhibitorsIfy R Mordi, Chim C Lang
Circulation|September 6, 2006
Letter by Struthers et al regarding article, "cross-sectional relations of multiple biomarkers from distinct biological pathways to brachial artery endothelial function"Allan D Struthers, Chim C Lang
Cardiovascular Therapeutics|May 12, 2009
Thiazolidinediones and the influence of media adverse reporting on prescribing attitudes in practice (TZD-IMPACT) studyJacob George, Stuart Hannah, Chim C Lang
Vascular Health and Risk Management|June 18, 2015
Angiotensin receptor-neprilysin inhibitors: clinical potential in heart failure and beyondJagdeep S S Singh, Chim C Lang
Journal of Cardiac Failure|October 10, 2007
Prognostic significance and measurement of exercise-derived hemodynamic variables in patients with heart failureChim C Lang, Piergiuseppe Agostoni, Donna M Mancini
Circulation|January 28, 2020
Letter by Mordi et al Regarding Article, "Metformin Use and Clinical Outcomes Among Patients With Diabetes Mellitus With or Without Heart Failure or Kidney Dysfunction: Observations From the SAVOR-TIMI 53 Trial"Ify R Mordi, Mohapradeep Mohan, Chim C Lang
Pageof 27